Talizumab

#	Item
1	Question 1 - Discussion Xolair dosing is based on serum IgE levels. Discuss the implications (if any) of dosing that could result in an increase in circulating levels of omalizumab-IgE immune complexes Add to Reading List Source URL: www.fda.gov Language: English Immune system Asthma Immunoglobulin E Medicine Talizumab Monoclonal antibodies Omalizumab Biology
2	DRAFT Advisory Committee Questions for PADAC November 18, 2009 meeting Add to Reading List Source URL: www.fda.gov Language: English Medicine Omalizumab Anatomy Asthma Allergy Immunoglobulin E Talizumab Tanox Monoclonal antibodies Biology Immune system
3	FOOD AND DRUG ADMINISTRATION (FDA) Add to Reading List Source URL: www.fda.gov Language: English Pharmaceutical sciences Clinical research Genentech Food and Drug Administration Asthma Center for Drug Evaluation and Research Talizumab Tanox Monoclonal antibodies Medicine Omalizumab
4	US Food and Drug Administration Meeting of the Pulmonary-Allergy Drugs Advisory Committee Add to Reading List Source URL: www.fda.gov Language: English Anatomy Monoclonal antibodies Immunology Omalizumab Asthma Immunoglobulin E Allergy Allergen Talizumab Medicine Immune system Biology